Changing therapeutic strategies and persistence to disease-modifying treatments in a population of Multiple Sclerosis patients from Veneto region, Italy

ConclusionThe use of the new oral DMTs greatly increased since their approval but persistence in the long-term is not better than with old drugs. The treatment choice is still a challenge both for patients and their doctors.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research